Abstract

Pharmacovigilance databases play a pivotal role in the proactive monitoring and assessment of drug safety. This article explores the essential functions of these databases in collecting, analyzing, and interpreting data related to adverse events associated with pharmaceutical products. The focus is on how Pharmacovigilance databases contribute to risk assessment, signal detection, regulatory compliance, and post-marketing surveillance. The challenges in maintaining data quality and completeness are discussed, along with advancements in data integration, interoperability, and the incorporation of artificial intelligence. As a critical component of pharmacovigilance, these databases are integral in ensuring the ongoing safety of drugs throughout their lifecycle